InsidersTradesSigma
Track the 리브스메드 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 리브스메드 has logged 5 reports. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 김욱은. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
리브스메드 在医疗保健和制药领域运营，并在 XKRX 市场上市。该公司专注于开发创新解决方案以提升医疗保健水平。